These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24033551)

  • 1. The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation.
    Eaton JE; Smyrk TC; Imam M; Pardi DS; Loftus EV; Owens VL; Talwalkar JA
    Aliment Pharmacol Ther; 2013 Oct; 38(8):977-87. PubMed ID: 24033551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
    Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis.
    Pekow JR; Hetzel JT; Rothe JA; Hanauer SB; Turner JR; Hart J; Noffsinger A; Huo D; Rubin DT
    Inflamm Bowel Dis; 2010 Aug; 16(8):1352-6. PubMed ID: 20027656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?
    Marelli L; Xirouchakis E; Kalambokis G; Cholongitas E; Hamilton MI; Burroughs AK
    Gut; 2011 Sep; 60(9):1224-8. PubMed ID: 21402617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
    Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.
    Navaneethan U; Kochhar G; Venkatesh PG; Lewis B; Lashner BA; Remzi FH; Shen B; Kiran RP
    Gastrointest Endosc; 2012 May; 75(5):1045-1054.e1. PubMed ID: 22405258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Course of Ulcerative Colitis After Liver Transplantation in Patients with Concomitant Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Fattahi MR; Malek-Hosseini SA; Sivandzadeh GR; Safarpour AR; Bagheri Lankarani K; Taghavi AR; Ejtehadi F
    Inflamm Bowel Dis; 2017 Jul; 23(7):1160-1167. PubMed ID: 28520586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Brentnall TA; Haggitt RC; Rabinovitch PS; Kimmey MB; Bronner MP; Levine DS; Kowdley KV; Stevens AC; Crispin DA; Emond M; Rubin CE
    Gastroenterology; 1996 Feb; 110(2):331-8. PubMed ID: 8566577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis.
    Fumery M; Dulai PS; Gupta S; Prokop LJ; Ramamoorthy S; Sandborn WJ; Singh S
    Clin Gastroenterol Hepatol; 2017 May; 15(5):665-674.e5. PubMed ID: 27916678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location.
    Goldstone R; Itzkowitz S; Harpaz N; Ullman T
    Gastrointest Endosc; 2011 Nov; 74(5):1087-93. PubMed ID: 21907984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoplasia in the ileoanal pouch following colectomy in patients with ulcerative colitis and primary sclerosing cholangitis.
    Imam MH; Eaton JE; Puckett JS; Loftus EV; Mathis KL; Gossard AA; Talwalkar JA; Lindor KD
    J Crohns Colitis; 2014 Oct; 8(10):1294-9. PubMed ID: 24768559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
    Lindberg BU; Broomé U; Persson B
    Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review with meta-analysis: incidence and factors for progression to advanced neoplasia in inflammatory bowel disease patients with indefinite and low-grade dysplasia.
    Wan J; Wang X; Zhang Y; Chen M; Wang M; Wu K; Liang J
    Aliment Pharmacol Ther; 2022 Mar; 55(6):632-644. PubMed ID: 35166389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon.
    Krugliak Cleveland N; Rubin DT; Hart J; Weber CR; Meckel K; Tran AL; Aelvoet AS; Pan I; Gonsalves A; Gaetano JN; Williams KM; Wroblewski K; Jabri B; Pekow J
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):68-74. PubMed ID: 28756053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of liver transplantation on the clinical course of colitis in ulcerative colitis patients with primary sclerosing cholangitis.
    Navaneethan U; Choudhary M; Venkatesh PG; Lashner BA; Remzi FH; Shen B; Kiran RP
    Aliment Pharmacol Ther; 2012 May; 35(9):1054-63. PubMed ID: 22428731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis.
    Pardi DS; Loftus EV; Kremers WK; Keach J; Lindor KD
    Gastroenterology; 2003 Apr; 124(4):889-93. PubMed ID: 12671884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
    Eaton JE; Silveira MG; Pardi DS; Sinakos E; Kowdley KV; Luketic VA; Harrison ME; McCashland T; Befeler AS; Harnois D; Jorgensen R; Petz J; Lindor KD
    Am J Gastroenterol; 2011 Sep; 106(9):1638-45. PubMed ID: 21556038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis.
    Navaneethan U; Venkatesh PG; Mukewar S; Lashner BA; Remzi FH; McCullough AJ; Kiran RP; Shen B; Fung JJ
    Clin Gastroenterol Hepatol; 2012 May; 10(5):540-6. PubMed ID: 22245961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.